Impact of TP53 functional mutation type on clinical outcomes of advanced breast cancer patients

被引：0
|
作者：
Stjepanovic, N. [1 ]
Garg, S. [1 ]
Berman, H. [1 ]
Warr, D. [1 ]
Amir, E. [1 ]
Cescon, D. [1 ]
Elser, C. [1 ]
Wang, L. [1 ]
Kamel-Reid, S. [1 ]
Siu, L. [1 ]
Bedard, P. L. [1 ]
Stockley, T. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P2-05-19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-05-19
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer
    Meric-Bernstam, Funda
    Zheng, Xiaofeng
    Shariati, Maryam
    Damodaran, Senthil
    Wathoo, Chetna
    Brusco, Lauren
    Demirhan, Mehmet Esat
    Tapia, Coya
    Eterovic, Agda Karina
    Basho, Reva K.
    Ueno, Naoto T.
    Janku, Filip
    Sahin, Aysegul
    Rodon, Jordi
    Broaddus, Russell
    Kim, Tae-Beom
    Mendelsohn, John
    Shaw, Kenna R. Mills
    Tripathy, Debu
    Mills, Gordon B.
    Chen, Ken
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 15
  • [2] Impact of TP53 Mutation in Advanced NSCLC in LATAM
    Runciman, T.
    Carracedo, C.
    Arrieta, O.
    Cruz-Rico, G.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S500 - S500
  • [3] TP53 Mutation Patterns in Breast Cancer Subgroups
    Dumay, A.
    Feugeas, J-P
    Wittmer, E.
    Lehmann-Che, J.
    Bertheau, P.
    Espie, M.
    de Cremoux, P.
    Andre, F.
    Sotiriou, C.
    Pusztai, L.
    de The, H.
    CANCER RESEARCH, 2011, 71
  • [4] TP53 mutation in triple negative breast cancer
    Nikolaidou, A.
    Botsfari, E.
    Goupou, E.
    Rouptsiou, E.
    Iosifidou, R.
    Patakiouta, F.
    VIRCHOWS ARCHIV, 2017, 471 : S302 - S302
  • [5] The impact of TP53 mutation and pathological response to neoadjuvant chemotherapy on triple negative breast cancer outcomes
    Mitri, Zahi
    Lin, Chih-Hsu
    Hess, Kenneth R.
    Thompson, Alastair
    Lichtarge, Olivier
    Hubbard, Rebekah
    Fu, Chunxiao
    Symmans, William F.
    Moulder-Thompson, Stacy L.
    CANCER RESEARCH, 2018, 78 (04)
  • [6] Functional genomics of TP53 mutations and its impact in breast cancer progression
    Pal, Anasuya
    Gonzalez-Malerva, Laura
    Eaton, Seron
    Guzman, Mayra
    Chow, Donald
    Yin, Hongwei
    Park, Jin
    Anderson, Karen
    LaBaer, Joshua
    CANCER RESEARCH, 2015, 75
  • [7] Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients
    Dobes, Petr
    Podhorec, Jan
    Coufal, Oldrich
    Jureckova, Andrea
    Petrakova, Katarina
    Vojtesek, Borivoj
    Hrstka, Roman
    ONCOLOGY REPORTS, 2014, 32 (04) : 1695 - 1702
  • [8] Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
    Alsner, J
    Yilmaz, M
    Guldberg, P
    Hansen, LL
    Overgaard, J
    CLINICAL CANCER RESEARCH, 2000, 6 (10) : 3923 - 3931
  • [9] Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
    J Alsner
    M Yilmaz
    P Guldberg
    LL Hansen
    J Overgaard
    Breast Cancer Research, 2 (Suppl 1)
  • [10] Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
    Li, Xuerui
    Chen, Xiaoqing
    Wen, Lingzhu
    Wang, Yulei
    Chen, Bo
    Xue, Yunlian
    Guo, Liping
    Liao, Ning
    THORACIC CANCER, 2020, 11 (07) : 1861 - 1868
12345